Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazurek, M. F.
Right arrow Articles by Martin, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazurek, M. F.
Right arrow Articles by Martin, J. B.
NEUROLOGY 1986;36:1133
© 1986 American Academy of Neurology

CSF vasopressin concentration is reduced in Alzheimer's disease

Michael F. Mazurek, John H. Growdon, M. Flint Beal and Joseph B. Martin

Department of Neurology, Massachusetts General Hospital. Boston, MA.

The concentration of arginine vasopressin (AVP) was measured in cerebrospinal fluid (CSF) by radioimmunoassay. Serial dilution curves and reversed-phase high-pressure liquid chromatography (HPLC) showed that the material measured behaved identically to authentic vasopressin. Levels of CSF AVP were reduced by 37% in Alzheimer's disease, but were normal in Huntington's disease, normal-pressure hydrocephalus, and several other neurologic disorders. On direct comparison, the CSF AVP concentration was significantly lower in Alzheimer's disease than in normal-pressure hydrocephalus. Low CSF levels of AVP may therefore assist in the identification of demented patients who are not likely to benefit from ventricular shunting.

Address correspondence and reprint requests to Dr. Mazurek, Department of Neurology, Research 4, Massachusetts General Hospital, Boston, MA 02114.

Supported by NIH grants NS 16367 and NIA P50AG051134. M.F. Mazurek is a Fellow of the Medical Research Council of Canada. M.F. Beal is supported by Young Investigator Award 1R23NS19867–1.

Presented in part at the thirty-sixth annual meeting of the American Academy of Neurology, Boston, MA, April 1984.

Accepted for publication December 18, 1985.




This article has been cited by other articles:


Home page
Arch SurgHome page
A. E. Luckey and C. J. Parsa
Fluid and Electrolytes in the Aged
Arch Surg, October 1, 2003; 138(10): 1055 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
E. F. Coccaro, R. J. Kavoussi, R. L. Hauger, T. B. Cooper, and C. F. Ferris
Cerebrospinal Fluid Vasopressin Levels: Correlates With Aggression and Serotonin Function in Personality-Disordered Subjects
Arch Gen Psychiatry, August 1, 1998; 55(8): 708 - 714.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.